Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.09.2012 | Case report

Leflunomide

First report of disseminated cutaneous and visceral Kaposi's sarcoma: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Lee SY, Jo YM, Chung WT, Kim SH, Kim SY, Roh MS, Lee SW.Disseminated cutaneous and visceral Kaposi sarcoma in a woman with rheumatoid arthritis receiving leflunomide. Rheumatology International 32: 1065-1068, No. 4, Apr 2012. Available from: URL: http://dx.doi.org/10.1007/s00296-009-1354-0 - South Korea Lee SY, Jo YM, Chung WT, Kim SH, Kim SY, Roh MS, Lee SW.Disseminated cutaneous and visceral Kaposi sarcoma in a woman with rheumatoid arthritis receiving leflunomide. Rheumatology International 32: 1065-1068, No. 4, Apr 2012. Available from: URL: http://​dx.​doi.​org/​10.​1007/​s00296-009-1354-0 - South Korea
Metadaten
Titel
Leflunomide
First report of disseminated cutaneous and visceral Kaposi's sarcoma: case report
Publikationsdatum
01.09.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214200-00106

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Clobetasol

Case report

Diphencyprone

Case report

Lenalidomide

Case report

Bevacizumab